Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yanqiao Ren PhD"'
Publikováno v:
Cancer Control, Vol 31 (2024)
Purpose To evaluate the efficacy and safety of transarterial chemoembolization (TACE) combined with regorafenib (hereafter, TACE-regorafenib) or camrelizumab (hereafter, TACE-camrelizumab) for treating hepatocellular carcinoma (HCC) with untreatable
Externí odkaz:
https://doaj.org/article/ccbfbece054b4117a9f2d8c8cbd0b1b0
Autor:
Yanqiao Ren PhD, Ziyi Liu MD, Joyman Makamure PhD, Xuefeng Kan PhD, Songlin Song PhD, Yiming Liu PhD, Kun Qian PhD, Chuansheng Zheng PhD, Bin Liang PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Purpose: The present retrospective study aimed to evaluate the efficacy and safety of camrelizumab addition to transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC) with TACE-related untreatable progression (UP). M
Externí odkaz:
https://doaj.org/article/b5709f10c9b54a51b79de14821d4255f